• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发灶不明的转移性神经内分泌肿瘤的外科治疗。

Surgery for metastatic neuroendocrine tumors with occult primaries.

机构信息

Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

出版信息

J Surg Res. 2013 Sep;184(1):221-7. doi: 10.1016/j.jss.2013.04.008. Epub 2013 Apr 25.

DOI:10.1016/j.jss.2013.04.008
PMID:23643298
Abstract

INTRODUCTION

Neuroendocrine tumors (NETs) frequently metastasize prior to diagnosis. Although metastases are often identifiable on conventional imaging studies, primary tumors, particularly those in the midgut, are frequently difficult to localize preoperatively.

MATERIALS AND METHODS

Patients with metastatic NETs with intact primaries were identified. Clinical and pathologic data were extracted from medical records. Primary tumors were classified as localized or occult based on preoperative imaging. The sensitivities and specificities of preoperative imaging modalities for identifying the primary tumors were calculated. Patient characteristics, tumor features, and survival in localized and occult cases were compared.

RESULTS

Sixty-one patients with an intact primary tumor and metastatic disease were identified. In 28 of these patients (46%), the primary tumor could not be localized preoperatively. A median of three different preoperative imaging studies were utilized. Patients with occult primaries were more likely to have a delay (>6 mo) in surgical referral from time of onset of symptoms (57% versus 27%, P = 0.02). Among the 28 patients with occult primary tumors, 18 (64%) were found to have radiographic evidence of mesenteric lymphadenopathy corresponding, in all but one case, to a small bowel primary. In all but three patients (89%), the primary tumor could be identified intraoperatively.

CONCLUSION

The primary tumor can be identified intraoperatively in a majority of patients with metastatic NETs, irrespective of preoperative localization status. Referral for surgical management should not, therefore, be influenced by the inability to localize the primary tumor.

摘要

简介

神经内分泌肿瘤(NETs)在诊断前常发生转移。尽管转移灶通常可在常规影像学研究中识别,但原发肿瘤,特别是起源于中肠的肿瘤,术前通常难以定位。

材料和方法

确定了具有完整原发肿瘤的转移性 NET 患者。从病历中提取临床和病理数据。根据术前影像学将原发肿瘤分为局限性或隐匿性。计算了术前影像学检查识别原发肿瘤的敏感性和特异性。比较了局限性和隐匿性病例的患者特征、肿瘤特征和生存情况。

结果

确定了 61 例具有完整原发肿瘤和转移疾病的患者。在这些患者中的 28 例(46%),术前无法定位原发肿瘤。中位数使用了三种不同的术前影像学研究。隐匿性原发肿瘤患者的手术转诊延迟(>6 个月)更常见(57%比 27%,P=0.02)。在 28 例隐匿性原发肿瘤患者中,18 例(64%)有肠系膜淋巴结病的影像学证据,除 1 例外,均对应小肠原发肿瘤。除 3 例患者(89%)外,所有患者均可在术中识别原发肿瘤。

结论

无论术前定位情况如何,大多数转移性 NET 患者的原发肿瘤都可以在术中识别。因此,不应因无法定位原发肿瘤而影响手术治疗的转诊。

相似文献

1
Surgery for metastatic neuroendocrine tumors with occult primaries.原发灶不明的转移性神经内分泌肿瘤的外科治疗。
J Surg Res. 2013 Sep;184(1):221-7. doi: 10.1016/j.jss.2013.04.008. Epub 2013 Apr 25.
2
Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.晚期神经内分泌肿瘤患者进行积极手术切除的发病率和死亡率。
Arch Surg. 2003 Aug;138(8):859-66. doi: 10.1001/archsurg.138.8.859.
3
[Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].[胰腺神经内分泌肿瘤患者的手术管理与长期生存——144例患者的经验]
Dtsch Med Wochenschr. 2007 Feb 2;132(5):195-200. doi: 10.1055/s-2007-959309.
4
Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.神经内分泌性肝转移瘤的射频消融:米德尔塞克斯医院的经验
Abdom Imaging. 2005 Jul-Aug;30(4):435-41. doi: 10.1007/s00261-004-0258-4.
5
[Liver transplantation in metastatic neuroendocrine tumors. Symptom-free intervals and cure possible].[转移性神经内分泌肿瘤的肝移植。无症状间期及治愈的可能性]
Lakartidningen. 2007;104(36):2519-23.
6
The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.积极手术干预对神经内分泌肿瘤肝转移和肠系膜转移的姑息治疗益处。
Surgery. 2008 Oct;144(4):645-51; discussion 651-3. doi: 10.1016/j.surg.2008.06.008.
7
Identification of unknown primary tumors in patients with neuroendocrine liver metastases.神经内分泌肝转移患者中未知原发肿瘤的鉴定。
Arch Surg. 2010 Mar;145(3):276-80. doi: 10.1001/archsurg.2010.10.
8
A single institution's experience with surgical cytoreduction of stage IV, well-differentiated, small bowel neuroendocrine tumors.一家医疗机构对 IV 期、分化良好的小肠神经内分泌肿瘤进行手术减瘤的经验。
J Am Coll Surg. 2014 Apr;218(4):837-44. doi: 10.1016/j.jamcollsurg.2013.12.035. Epub 2014 Jan 10.
9
Surgery on neuroendocrine tumours.神经内分泌肿瘤手术
Best Pract Res Clin Endocrinol Metab. 2007 Mar;21(1):87-109. doi: 10.1016/j.beem.2006.12.004.
10
[Imaging methods in diagnosis of neuroendocrine tumors of the gastrointestinal tract].[胃肠道神经内分泌肿瘤诊断中的影像学方法]
Bildgebung. 1995 Mar;62(1):5-13.

引用本文的文献

1
Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.头颈部、泌尿生殖系统及妇科系统神经内分泌肿瘤、原发灶不明肿瘤、甲状旁腺癌及甲状腺内胸腺肿瘤:ESMO临床实践指南之诊断、治疗及随访
ESMO Open. 2024 Oct;9(10):103664. doi: 10.1016/j.esmoop.2024.103664. Epub 2024 Oct 1.
2
Diagnostic Approaches for Neuroendocrine Neoplasms of Unknown Primary (NEN-UPs) and Their Prognostic Relevance-A Retrospective, Long-Term Single-Center Experience.未知原发灶神经内分泌肿瘤(NEN-UPs)的诊断方法及其预后相关性——一项回顾性、长期单中心经验
Cancers (Basel). 2023 Aug 29;15(17):4316. doi: 10.3390/cancers15174316.
3
Performance of Multidetector Computed Tomography and Negative Versus Positive Enteric Contrast for Evaluation of Gastrointestinal Neuroendocrine Neoplasms.多排螺旋 CT 与阴性对比剂与阳性对比剂在胃肠道神经内分泌肿瘤评估中的性能比较。
J Comput Assist Tomogr. 2022;46(3):333-343. doi: 10.1097/RCT.0000000000001291. Epub 2022 Mar 4.
4
An abdominal wall neuroendocrine tumor of unknown primary origin: A case report and review of the literature.原发灶不明的腹壁神经内分泌肿瘤 1 例报告并文献复习
Cancer Rep (Hoboken). 2022 Sep;5(9):e1610. doi: 10.1002/cnr2.1610. Epub 2022 Feb 10.
5
ALT Positivity in Human Cancers: Prevalence and Clinical Insights.人类癌症中的谷丙转氨酶阳性:患病率及临床见解
Cancers (Basel). 2021 May 14;13(10):2384. doi: 10.3390/cancers13102384.
6
Small Bowel Neuroendocrine Tumors.小肠神经内分泌肿瘤
Curr Probl Surg. 2020 Dec;57(12):100823. doi: 10.1016/j.cpsurg.2020.100823. Epub 2020 May 15.
7
Surgical management of Zollinger-Ellison syndrome: Classical considerations and current controversies.《Zollinger-Ellison 综合征的外科治疗:经典观点与当前争议》。
World J Gastroenterol. 2019 Aug 28;25(32):4673-4681. doi: 10.3748/wjg.v25.i32.4673.
8
THE ROLE OF SURGERY IN A PATIENT WITH CARCINOID SYNDROME, COMPLICATED BY CARCINOID HEART DISEASE.手术在类癌综合征合并类癌性心脏病患者中的作用。
Acta Endocrinol (Buchar). 2018 Jan-Mar;14(1):117-121. doi: 10.4183/aeb.2018.117.
9
Influence of carcinoid syndrome on the clinical characteristics and outcomes of patients with gastroenteropancreatic neuroendocrine tumors undergoing operative resection.类癌综合征对胃肠胰神经内分泌肿瘤患者手术切除的临床特征和结局的影响。
Surgery. 2019 Mar;165(3):657-663. doi: 10.1016/j.surg.2018.09.008. Epub 2018 Oct 28.
10
The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society.小肠神经内分泌肿瘤的外科治疗:北美神经内分泌肿瘤学会共识指南
Pancreas. 2017 Jul;46(6):715-731. doi: 10.1097/MPA.0000000000000846.